The competition, which recognizes the best image produced from cancer research conducted by the ICR and its partner The Royal Marsden National Health Service (NHS)Foundation Trust, has been winnowed down to a shortlist of six contenders. The six candidates cover a range of cancer research fields and various scientific techniques, including mouse xenografts, tumor spheroids, and immunohistochemistry staining, according to the ICR.

The winning image will be chosen by a panel of judges from the ICR and Royal Marsden, while the favorite image will be selected by the public. Votes can be cast over the next two weeks on the ICR's website.

Multiomics approach profiles molecular characteristics of glioblastoma
A team of more than 40 investigators has created a profile of the genes, proteins, infiltrating cells, and signaling pathways of the deadly brain cancer...

NanoString tech helps profile cancer-immune states in tumors
A new article in Nature Medicine provides insights into cancer tissues by using NanoString Technology's GeoMx Digital Spatial Profiler and its...

New synthetic biology approach may improve delivery of programmable medicines
Programmable medicines that can be controlled by synthetic genetic components are not yet a clinical reality. But synthetic components can now be reconfigured...

Novel microscopy method unlocks clues to nanomedicine interactions
A new mixed microscopy method has led to a better understanding of the interactions of proteins in the body with nanoparticles used for biotherapeutic...

What makes immuno-oncology therapies attractive investments?
Although immuno-oncology therapies have been around for many years, investors are excited to partner with innovators in the space who can push the boundaries...